Curto R, Voit E O, Sorribas A, Cascante M
Departament de Bioquímica i Biología Molecular, Facultat de Químiques, Universitat de Barcelona, 08028 Barcelona, Catalunya, Spain.
Biochem J. 1997 Jun 15;324 ( Pt 3)(Pt 3):761-75. doi: 10.1042/bj3240761.
The paper introduces a model of human purine metabolism in situ. Chosen from among several alternative system descriptions, the model is formulated as a Generalized Mass Action system within Biochemical Systems Theory and validated with analyses of steady-state and dynamic characteristics. Eigenvalue and sensitivity analyses indicate that the model has a stable and robust steady-state. The model quite accurately reproduces numerous biochemical and clinical observations in healthy subjects as well as in patients with disorders of purine metabolism. These results suggest that the model can be used to assess biochemical and clinical aspects of human purine metabolism. It provides a means of exploring effects of enzyme deficiencies and is a potential tool for identifying steps of the pathway that could be the target of therapeutical intervention. Numerous quantitative comparisons with data are given. The model can be used for biomathematical exploration of relationships between enzymic deficiencies and clinically manifested diseases.
本文介绍了一种人体嘌呤代谢原位模型。该模型是从几种备选系统描述中挑选出来的,在生化系统理论中被表述为广义质量作用系统,并通过对稳态和动态特性的分析进行了验证。特征值和敏感性分析表明该模型具有稳定且稳健的稳态。该模型相当准确地再现了健康受试者以及嘌呤代谢紊乱患者的众多生化和临床观察结果。这些结果表明,该模型可用于评估人体嘌呤代谢的生化和临床方面。它提供了一种探索酶缺乏效应的方法,并且是识别该途径中可能成为治疗干预靶点步骤的潜在工具。文中给出了与数据的大量定量比较。该模型可用于对酶缺乏与临床表现疾病之间关系的生物数学探索。